Login
AbbVie posted stronger-than-expected earnings and raised its profit outlook
30 October 2026 at 13:00
The drugmaker is raising its quarterly dividend 5.2% to $1.82 a share, and revenue grew 10.3% to $17.404 billion
Normal view
Tylenol maker Kenvue reported higher profit and a fourth straight quarter of sales growth
30 October 2026 at 12:30
Net sales rose 3.2% to $3.89 billion as Self Care and Essential Health grew, ahead of Kimberly-Clark's planned acquisition
AstraZeneca is launching a $1.5 billion cost-savings program to fund its drug pipeline
30 October 2026 at 12:10
The drugmaker expects one-time restructuring costs of up to $2 billion as it redeploys resources over three years
